Trial Profile
Comparison of acid inhibition attained by Vonoprazan with or without Lafutidine.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 May 2017
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary) ; Lafutidine
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- 23 May 2017 Status changed from active, no longer recruiting to completed.
- 23 Feb 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 11 Jul 2016 New trial record